Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies-Reference-Cited by-同舟云学术

Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies

Published:2018-06 Issue:6 Volume:73 Page:847-855
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Gravis Gwenaelle,Boher Jean-Marie,Chen Yu-Hui,Liu Glenn,Fizazi Karim,Carducci Michael A.,Oudard Stephane,Joly Florence,Jarrard David M.,Soulie Michel,Eisenberger Mario J.,Habibian Muriel,Dreicer Robert,Garcia Jorge A.,Hussain Maha H.M.,Kohli Manish,Vogelzang Nicholas J.,Picus Joel,DiPaola Robert,Sweeney Christopher

Publisher

Elsevier BV

Subject

Urology

Reference28 articles.

1. Prostate cancer: estimated incidence, mortality and prevalence worldwide,2012

2. Les cancers en France/edition 2015,2016

3. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004

4. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

5. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial;de Bono;Lancet,2010

Cited by 191 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety evaluation of androgen deprivation therapy-based combinations for metastatic castration-sensitive prostate cancer: a systematic review and network meta-analysis;British Journal of Cancer;2024-09-02

2. Metastatic hormone-naïve prostate cancer: a distinct biological entity;Trends in Cancer;2024-09

3. ASO Author Reflections: It Does Not Matter Whether Radical Prostatectomy is Performed in High-Risk Localized Disease or at the Oligometastatic Stage;Annals of Surgical Oncology;2024-08-29

4. Cholesterol Metabolism and Urinary System Tumors;Biomedicines;2024-08-12

5. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer;European Urology;2024-08